Curaleaf in hot water with FDA over ‘improper health claims’

The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety ...

Restricted content. Do you want to read more?